Tapinarof for the Treatment of Plaque Psoriasis in Pediatric Subjects

PHASE3RecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

December 2, 2021

Primary Completion Date

September 30, 2026

Study Completion Date

September 30, 2026

Conditions
Plaque Psoriasis
Interventions
DRUG

tapinarof cream, 1%

applied topically once daily

Trial Locations (19)

33014

RECRUITING

RM Medical Research, Miami Lakes

RECRUITING

San Marcus Research Clinic, Inc., Miami Lakes

33615

ACTIVE_NOT_RECRUITING

Olympian Clinical Research, Tampa

45324

RECRUITING

Wright State Physicians Pharmacology Translational Unit, Fairborn

46250

RECRUITING

Dawes Fretzin Clinical Research Group, Indianapolis

47906

RECRUITING

Options Research Group, West Lafayette

60611

RECRUITING

Northwestern University Feinberg School of Medicine, Chicago

72758

RECRUITING

Northwest Arkansas Clinical Trials Center, PLLC, Rogers

92688

RECRUITING

Mission Dermatology Center, Rancho Santa Margarita

92708

RECRUITING

First OC Dermatology, Fountain Valley

97210

ACTIVE_NOT_RECRUITING

Oregon Dermatology & Research Center, Portland

99202

RECRUITING

Dermatology Specialists of Spokane, Spokane

T2J7E1

RECRUITING

Dermatology Research Institute Inc., Calgary

T5J3S9

RECRUITING

Rejuvenation Laser Dermatology Clinics, Edmonton

A1E1V4

RECRUITING

Skincare Studio INC, St. John's

L3P1X3

RECRUITING

Lynderm Research Inc., Markham

N2J 1C4

RECRUITING

Alliance Clinical Trials, Waterloo

L1P0P9

ACTIVE_NOT_RECRUITING

Whitby Health Centre Dermatology Trials, Whitby

H2X 2V1

RECRUITING

Innovaderm Research, Inc., Montreal

All Listed Sponsors
lead

Organon and Co

INDUSTRY

NCT05172726 - Tapinarof for the Treatment of Plaque Psoriasis in Pediatric Subjects | Biotech Hunter | Biotech Hunter